Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL


Study Number
431919
Phase
I
Age Group
Adult
Pediatric
Purpose

This research study is evaluating a drug called ribociclib (LEE011) given in combination with everolimus and other standard of care chemotherapy drugs as a possible treatment for relapsed or refractory ALL. The names of the drugs involved in this study are: - ribociclib - everolimus - dexamethasone

Full Title

Phase I trial of ribociclib in combination with everolimus and dexamethasone in children and young adults with relapsed acute lymphoblastic leukemia

ClinicalTrials.Gov ID
NCT03740334

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.